Abstract
OBJECTIVE: This study was undertaken to determine the effects of transjugular intrahepatic portasystemic shunt (TIPS) and small-diameter prosthetic H-graft portacaval shunt (HGPCS) on portal and effective hepatic blood flow. SUMMARY BACKGROUND DATA: Mortality after TIPS is higher than after HGPCS for bleeding varices. This higher mortality is because of hepatic failure, possibly a result of excessive diminution of hepatic blood flow. METHODS: Forty patients randomized prospectively to undergo TIPS or HGPCS had effective hepatic blood flow determined 1 day preshunt and 5 days postshunt using low-dose galactose clearance. Portal blood flow was determined using color-flow Doppler ultrasound. RESULTS: Treatment groups were similar in age, gender, and Child's class. Each procedure significantly reduced portal pressures and portasystemic pressure gradients. Portal flow after TIPS increased (21 mL/second +/- 11.9 to 31 mL/second +/- 16.9, p < 0.05), whereas it remained unchanged after HGPCS (26 mL/second +/- 27.7 to 14 mL/second +/- 41.1, p = n.s.). Effective hepatic blood flow was diminished significantly after TIPS (1684 mL/minute +/- 2161 to 676 mL/minute +/- 451, p < 0.05) and was unaffected by HGPCS (1901 mL/ minute +/- 1818 to 1662 mL/minute +/- 1035, p = n.s.). CONCLUSIONS: Both TIPS and HGPCS achieved significant reductions in portal vein pressure gradients. Portal flow increased after TIPS, although most portal flow was diverted through the shunt. Effective hepatic flow is reduced significantly after TIPS but well preserved after HGPCS. Hepatic decompensation and mortality after TIPS may be because, at least in part, of reductions in nutrient hepatic flow.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Colcher H., Patek A. J., Jr, Kendall F. E. GALACTOSE DISAPPEARANCE FROM THE BLOOD STREAM. CALCULATION OF A GALACTOSE REMOVAL CONSTANT AND ITS APPLICATION AS A TEST FOR LIVER FUNCTION. J Clin Invest. 1946 Sep;25(5):768–775. doi: 10.1172/JCI101761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coldwell D. M., Ring E. J., Rees C. R., Zemel G., Darcy M. D., Haskal Z. J., McKusick M. A., Greenfield A. J. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology. 1995 Aug;196(2):335–340. doi: 10.1148/radiology.196.2.7617842. [DOI] [PubMed] [Google Scholar]
- Collins J. C., Sarfeh I. J. Surgical management of portal hypertension. West J Med. 1995 Jun;162(6):527–535. [PMC free article] [PubMed] [Google Scholar]
- Conn H. O. Transjugular intrahepatic portal-systemic shunts: the state of the art. Hepatology. 1993 Jan;17(1):148–158. [PubMed] [Google Scholar]
- Forster J., Delcore R., Payne K. M., Siegel E. L. The role of transjugular intrahepatic portosystemic shunts in the management of patients with end-stage liver disease. Am J Surg. 1994 Dec;168(6):592–597. [PubMed] [Google Scholar]
- Helton W. S., Belshaw A., Althaus S., Park S., Coldwell D., Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg. 1993 May;165(5):566–571. doi: 10.1016/s0002-9610(05)80436-2. [DOI] [PubMed] [Google Scholar]
- Henderson J. M., Fales F. W. Continuous-flow fluorometry of low galactose concentrations in blood or plasma. Clin Chem. 1980 Feb;26(2):282–285. [PubMed] [Google Scholar]
- Henderson J. M., Kutner M. H., Bain R. P. First-order clearance of plasma galactose: the effect of liver disease. Gastroenterology. 1982 Nov;83(5):1090–1096. [PubMed] [Google Scholar]
- LaBerge J. M., Ring E. J., Gordon R. L., Lake J. R., Doherty M. M., Somberg K. A., Roberts J. P., Ascher N. L. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993 May;187(2):413–420. doi: 10.1148/radiology.187.2.8475283. [DOI] [PubMed] [Google Scholar]
- LaBerge J. M., Somberg K. A., Lake J. R., Gordon R. L., Kerlan R. K., Jr, Ascher N. L., Roberts J. P., Simor M. M., Doherty C. A., Hahn J. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology. 1995 Apr;108(4):1143–1151. doi: 10.1016/0016-5085(95)90213-9. [DOI] [PubMed] [Google Scholar]
- Lind C. D., Malisch T. W., Chong W. K., Richards W. O., Pinson C. W., Meranze S. G., Mazer M. Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement. Gastroenterology. 1994 May;106(5):1277–1283. doi: 10.1016/0016-5085(94)90020-5. [DOI] [PubMed] [Google Scholar]
- Martin M., Zajko A. B., Orons P. D., Dodd G., Wright H., Colangelo J., Tartar R. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery. 1993 Oct;114(4):719–727. [PubMed] [Google Scholar]
- Miller-Catchpole R. Diagnostic and therapeutic technology assessment. Transjugular intrahepatic portosystemic shunt (TIPS). JAMA. 1995 Jun 21;273(23):1824–1830. [PubMed] [Google Scholar]
- Radosevich P. M., LaBerge J. M., Gordon R. L. Current status and future possibilities of transjugular intrahepatic portosystemic shunts in the management of portal hypertension. World J Surg. 1994 Sep-Oct;18(5):785–789. doi: 10.1007/BF00298933. [DOI] [PubMed] [Google Scholar]
- Rosemurgy A. S., Goode S. E., Zwiebel B. R., Black T. J., Brady P. G. A prospective trial of transjugular intrahepatic portasystemic stent shunts versus small-diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg. 1996 Sep;224(3):378–386. doi: 10.1097/00000658-199609000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rosemurgy A. S., McAllister E. W., Kearney R. E. Prospective study of a prosthetic H-graft portacaval shunt. Am J Surg. 1991 Jan;161(1):159–164. doi: 10.1016/0002-9610(91)90378-q. [DOI] [PubMed] [Google Scholar]
- Rubin R. A., Haskal Z. J., O'Brien C. B., Cope C., Brass C. A. Transjugular intrahepatic portosystemic shunting: decreased survival for patients with high APACHE II scores. Am J Gastroenterol. 1995 Apr;90(4):556–563. [PubMed] [Google Scholar]
- Rössle M., Haag K., Ochs A., Sellinger M., Nöldge G., Perarnau J. M., Berger E., Blum U., Gabelmann A., Hauenstein K. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994 Jan 20;330(3):165–171. doi: 10.1056/NEJM199401203300303. [DOI] [PubMed] [Google Scholar]
- Schirmer W. J., Townsend M. C., Schirmer J. M., Hampton W. W., Fry D. E. Galactose clearance as an estimate of effective hepatic blood flow: validation and limitations. J Surg Res. 1986 Nov;41(5):543–556. doi: 10.1016/0022-4804(86)90174-5. [DOI] [PubMed] [Google Scholar]
- Soper N. J., Rikkers L. F., Davis E. K. Hepatic blood flow measurement: comparison of indocyanine green and low-dose galactose clearance techniques. Curr Surg. 1984 Nov-Dec;41(6):455–457. [PubMed] [Google Scholar]
- Spiess S. E., Matalon T. A., Jensen D. M., Rosenblate H. J., Brunner M. C., Ganger D. R. Transjugular intrahepatic portosystemic shunt in nonliver transplant candidates: is it indicated? Am J Gastroenterol. 1995 Aug;90(8):1238–1243. [PubMed] [Google Scholar]
- TYGSTRUP N., WINKLER K. Galactose blood clearance as a measure of hepatic blood flow. Clin Sci. 1958 Feb;17(1):1–9. [PubMed] [Google Scholar]
- Wong F., Sniderman K., Liu P., Allidina Y., Sherman M., Blendis L. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med. 1995 Jun 1;122(11):816–822. doi: 10.7326/0003-4819-122-11-199506010-00002. [DOI] [PubMed] [Google Scholar]